Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Options Exercise Instructions
    • Top 40 Shareholders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

ASX Announcements 2003

  • 17 Dec 2003

    Publication of discovery of a drug that blocks ion channel activity associated with the P7 protein of Hepatitis C virus

  • 24 Nov 2003

    Biotron awarded Australian government grant

  • 7 Nov 2003

    Presentation to the annual general meeting

  • 29 Oct 2003

    Quarterly Report 30 September 2003

  • 21 Oct 2003

    Annual report for the year ended 30 June 2003

  • 8 Oct 2003

    2003 Financial report

  • 3 Sep 2003

    Potential new therapy for dengue

  • 28 Jul 2003

    Quarterly Report 30 June 2003

  • 27 Jul 2003

    Potential new therapy for SARS

  • 1 Jul 2003

    Potential new therapy for Hepatitis C

  • 14 Mar 2003

    Shareholder update

  • 6 Mar 2003

    Half year financial report 31 December 2002

  • 6 Mar 2003

    Half-year report 31 December 2002

  • 31 Jan 2003

    Quarterly Report 31 December 2002

  • 11 Jan 2003

    Release of escrow shares

  • <<
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • >>

Investor Centre

  • Investor Centre
    • ASX Announcements
    • Annual reports
    • Corporate Directory
    • Shareholder services
    • Top 40 Shareholders
    • Corporate Governance
    • Corporate Presentations
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 30 May 2022        Legal Notices and Privacy